The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN
Abstract
Abstract— The effect of l‐tryptophan loading upon the amount of 5‐HT accumulating in the brains of rats pretreated with a monoamine oxidase inhibitor was studied. The amount of brain 5‐HT accumulated increased with increasing tryptophan dosages and brain tryptophan concentrations up to a tryptophan dose of 120 mg/kg body wt. and a brain tryptophan of about 70 μg/g brain. Above this dose and concentration no further increase in brain 5‐HT accumulation occurred. After monoamine oxidase inhibition and tryptophan loading gross hyperactivity and hyperpyrexia occurred. Monoamine oxidase inhibition, tryptophan administration and intact aromatic amino acid decarboxylase activity were all collectively essential for the production of hyperactivity and hyperpyrexia. DL‐Parachlorophenyl‐alanine prevented both the occurrence of hyperactivity and the increased accumulation of, brain 5‐HT. Indices of hyperactivity correlated with the amount of brain 5‐HT accumulating in 1 h after tryptophan loading but not with the overall concentration of brain 5‐HT, suggesting that hyperactivity was dependent upon the rate of 5‐HT synthesis. Reserpine and tetra‐benazine pretreatment speeded the onset and rate of development of the hyperactive state without altering the synthesis of brain 5‐HT. It is suggested that when monoamine oxidase is inhibited and the rate of 5‐HT synthesis is increased, granular uptake and storage of 5‐HT and other rate‐limiting mechanisms for 5‐HT inactivation are unable to prevent 5‐HT 'spilling over’to produce hyperactivity. The crucial dependence of 5‐HT synthesis upon brain tryptophan concentration and the ability of intraneuronal metabolism, when monoamine oxidase activity is intact, to cope with increased 5‐HT synthesis and prevent ‘spillover’, raise the possibility that brain 5‐HT synthesis is normally in excess of functional needs, and suggest that intraneuronal metabolism and the intraneuronal organization of 5‐HT pools are of more importance than synthesis in regulating the amount of 5‐HT available for functional activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allosteric proteins and cellular control systems
Monod, J., Changeux, J.-P., & Jacob, F. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80091-1 · Cited by 2,233
p-CHLOROPHENYLALANINE: A SPECIFIC DEPLETOR OF BRAIN SEROTONIN
Koe, B. K., & Weissman, A. (1966) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27497-3 · Cited by 1,783
Aromatic l-Amino Acid Decarboxylase
Lovenberg, W., Weissbach, H., & Udenfriend, S. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81366-7 · Cited by 845
The determination of tryptophan in plasma, liver, and urine.
Denckla, W. D., & Dewey, H. K. (1967) · PubMed · Cited by 823
THE EFFECTS OF PRECURSOR LOADING IN THE CEREBRAL METABOLISM OF 5‐HYDROXYINDOLES
Moir, A. T. B., & Eccleston, D. (1968) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1968.tb06827.x · Cited by 396
Tozer, T. N., Neff, N. H., & Brodie, B. B. (1966) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27378-5 · Cited by 313
INCREASE IN TISSUE SEROTONIN FOLLOWING ADMINISTRATION OF ITS PRECURSOR 5-HYDROXYTRYPTOPHAN
Udenfriend, S., Weissbach, H., & Bogdanski, D. F. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64972-5 · Cited by 271
A FLUOROMETRIC PROCEDURE FOR THE MEASUREMENT OF TRYPTAMINE IN TISSUES
Hess, S. M., & Udenfriend, S. (1959) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25679-8 · Cited by 235
Tryptophan hydroxylation in brain
Grahame-Smith, D. G. (1964) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(64)90197-4 · Cited by 196
Self-citationAnsell, G. B., & Beeson, M. F. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90351-5 · Cited by 180
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain
Gao, K., Mu, C.-L., Farzi, A., & Zhu, W.-Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz127 · Cited by 1,029
Tryptophan metabolism in the central nervous system: medical implications
Ruddick, J. P., Evans, A. K., Nutt, D. J., Lightman, S. L., Rook, G. A. W., & Lowry, C. A. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406000068 · Cited by 519
Serotonergic facilitation of facial motoneuron excitation
McCall], R. B., & Aghajanian, G. K. (1979) · Brain Research · doi:10.1016/0006-8993(79)90370-6 · Cited by 444
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Halberstadt, A. L., & Geyer, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.017 · Cited by 411
Metadata
- Authors
- Grahame‐Smith, D. G.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 1971-06
- Volume
- 18
- Issue
- 6
- Pages
- 1053-1066
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2004895078
- Cited by
- 665
- References
- 16
- FWCI
- 12.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN. https://app.cochat.ai/papers/10.1111/j.1471-4159.1971.tb12034.x
- The paper
- Grahame‐Smith, D. G. (1971). STUDIES IN VIVO ON THE RELATIONSHIP BETWEEN BRAIN TRYPTOPHAN, BRAIN 5‐HT SYNTHESIS AND HYPERACTIVITY IN RATS TREATED WITH A MONOAMINE OXIDASE INHIBITOR AND L‐TRYPTOPHAN. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.1971.tb12034.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.